+5麦粒
张莹
苏州大学附属第一医院 乳腺外科
视频
Tislelizumab Augment the Efficacy of CD19/22 Dual-Targeted Chimeric Antigen ReceptorT cells in Advanced Stage Relapsed or Refractory B-cell Non -Hodgkin Lymphoma
2023-04-14
奕凯达首例患者病例分享
2021-12-23
1
2